CCND2 and breast carcinoma: In addition, CCND2 promoter hypermethylation was detected in plasma circulating cell-free DNA from 8 of 18 (44.4%) of breast cancer patients, and little CCND2 promoter hypermethylation was detected in women without breast cancer (3 of 19, 15.8%).